8-K: Investview Inc. Announces Share Repurchase and Acquisition of Renu Laboratories

Investview, Inc. has announced the repurchase of 121 million shares and the acquisition of Renu Laboratories, a health and wellness product manufacturer.

Summary

• Investview, Inc. has agreed to repurchase 121 million shares of its common stock from three non-affiliate shareholders, representing approximately 6.5% of the company's outstanding shares.
• The shares were initially issued in 2017, and the repurchase aims to resolve a related dispute.
• The repurchase will reduce the company's outstanding shares from 1,859,231,786 to 1,738,231,786.
• The purchase price will be paid in 10 equal consecutive quarterly payments after the closing.
• Investview has also acquired Renu Laboratories, a manufacturer of health, beauty, and wellness products.
• The acquisition is intended to expand Investview's business into the health and wellness market.
• Renu Labs has a catalog of proprietary and third-party skin, body, hair, nutritional supplement, and personal care products.
• Investview plans to operate the Renu Labs business under a new myLife Wellness business unit using a direct-to-consumer model.
• The company expects the Renu acquisition to be revenue accretive as early as the fourth quarter of 2024 or the first quarter of 2025.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with the acquisition and share repurchase, but also acknowledges risks and uncertainties. The sentiment is generally optimistic, but tempered by the forward-looking nature of the statements.

Positives

• The share repurchase reduces the number of outstanding shares, potentially increasing earnings per share.
• The resolution of the 2017 dispute removes a potential legal overhang.
• The acquisition of Renu Laboratories diversifies Investview's business into the growing health and wellness market.
• Renu Labs has a proven track record and a catalog of proprietary products.
• The direct-to-consumer model leverages Investview's existing distribution network.
• The acquisition is expected to be revenue accretive in the near term.
• Renu Labs has over 30 years of experience as a recognized OTC skin care manufacturer.

Negatives

• The share repurchase is being done at a discount to the current share price.
• The purchase price for the shares will be paid over 10 quarters, which could impact cash flow.
• The integration of Renu Labs may present challenges and require additional investment.
• The success of the new myLife Wellness business unit is not guaranteed.
• The company is relying on forward-looking statements that may not materialize.

Risks

• The closing of the share repurchase is subject to customary closing conditions and may not be completed.
• The integration of Renu Labs may not be successful, and the expected synergies may not be realized.
• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• The company may face challenges in expanding Renu's operations and product offerings.
• There is no guarantee that the Renu acquisition will be accretive to earnings.

Future Outlook

Investview expects the Renu acquisition to be revenue accretive as early as the fourth quarter of 2024 or the first quarter of 2025. The company plans to expand Renu's operations and product offerings through capital investment and leveraging its existing sales and marketing channels.

Management Comments

• Victor Oviedo, Investview CEO, stated that the acquisition of Renu Labs is an exciting milestone for the company's strategic growth plans.
• Victor Oviedo commented that the combination of Renu Labs with existing businesses is intended to further support the mission and vision at Investview to create and offer unique quality of life products and services.
• Jim Bell, Investview President/COO, added that the Renu acquisition is a great addition to the company and positions them to diversify into the health and wellness markets.
• Gregg Hanson, Founder and President of Renu Labs, commented that joining forces with Investview marks a pivotal moment for them and will allow them to accelerate innovation.

Industry Context

The acquisition of Renu Laboratories reflects a trend of companies diversifying into the health and wellness sector, which is experiencing significant growth. This move allows Investview to leverage its existing distribution network and customer base to expand into a new market.

Comparison to Industry Standards

• The acquisition of a health and wellness company is a common strategy for companies looking to diversify their revenue streams, similar to how companies like Unilever and Proctor & Gamble have expanded into personal care.
• The direct-to-consumer model is also a popular approach in the health and wellness industry, with companies like Dollar Shave Club and Warby Parker demonstrating its effectiveness.
• The share repurchase is a common method for companies to return value to shareholders, similar to programs implemented by companies like Apple and Microsoft.
• The 6.5% share reduction is a moderate amount compared to some companies that have repurchased larger percentages of their outstanding shares.

Stakeholder Impact

• Shareholders will benefit from the reduced number of outstanding shares and potential increase in earnings per share.
• Customers will have access to a wider range of health and wellness products.
• Employees of Renu Labs will become part of a larger organization.
• Suppliers of Renu Labs will have access to a larger market.

Next Steps

• The company will complete the closing of the share repurchase agreement.
• The company will integrate Renu Laboratories into its operations.
• The company will launch the myLife Wellness business unit.
• The company will develop and implement a marketing strategy for Renu products.
• The company will work to expand Renu's operations and product offerings.

Key Dates

Keywords

share repurchase, acquisition, Renu Laboratories, health and wellness, direct-to-consumer, myLife Wellness, iGenius, skincare, OTC products, financial technology